Log in
Enquire now
‌

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study

OverviewStructured DataIssuesContributors
Is a
‌
Clinical study
0
Trial Collaborator
Alzheimer's Association
Alzheimer's Association
0
Participating Facility
University of Nebraska Medical Center
University of Nebraska Medical Center
0
Howard University
Howard University
0
Rush University Medical Center
Rush University Medical Center
0
University of Rochester Medical Center
University of Rochester Medical Center
0
Rhode Island Hospital
Rhode Island Hospital
0
‌
Dent Neurologic Institute
0
‌
Roper St. Francis Healthcare
0
‌
Banner Alzheimer's Institute
0
Johns Hopkins University
Johns Hopkins University
0
‌
Yale University School of Medicine
0
•••
Last Updated
November 18, 2023
0
Observational Study Perspective
Prospective
0
Observational Clinical Trial Type
Cohort
0
Primary Completion Date
September 29, 2023
0
Trial Recruitment Size
538
0
Trial Sponsor
University of Southern California
University of Southern California
0
Clinical Trial Start Date
September 8, 2015
0
Study Completion Date
September 29, 2023
0
Clinical Trial Study Type
Observational
0
NCT Number
NCT02488720
0
Official Name
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
0
Official Website
clinicaltrials.gov/study...488720
0

Find more entities like Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.